chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sick; everything tasted like raw sewage and nothing tastes like it is supposed to; everything smelled like raw sewage and nothing smells like it is supposed to; body oil smells like raw sewage; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), AGEUSIA (everything tasted like raw sewage and nothing tastes like it is supposed to), ANOSMIA (everything smelled like raw sewage and nothing smells like it is supposed to), SKIN ODOUR ABNORMAL (body oil smells like raw sewage) and NAUSEA (nauseous) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), MORPHINE, METAXALONE (FLEXURA), PROCATEROL, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), MULTIVITAMINS [VITAMINS NOS], DILOXANIDE FUROATE, METRONIDAZOLE (DIAZOLE [DILOXANIDE FUROATE;METRONIDAZOLE]) and OMEPRAZOLE (PROPIZOLE) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick), AGEUSIA (everything tasted like raw sewage and nothing tastes like it is supposed to), ANOSMIA (everything smelled like raw sewage and nothing smells like it is supposed to), SKIN ODOUR ABNORMAL (body oil smells like raw sewage) and NAUSEA (nauseous). At the time of the report, ILLNESS (sick), AGEUSIA (everything tasted like raw sewage and nothing tastes like it is supposed to), ANOSMIA (everything smelled like raw sewage and nothing smells like it is supposed to), SKIN ODOUR ABNORMAL (body oil smells like raw sewage) and NAUSEA (nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test: unknown (Positive) Positive.         No treatment medications were provided by the reporter.   This case was linked to MOD-2021-230022 (Patient Link).
Scab on scalp started in early to mid July.   Then more came.  The dr said it was a small case of shingles.  Soon after my eye started getting the scabs around it.  I went to the eye dr to make sure shingles was not in my eye as my vision was having trouble.  He checked and didn't see any in the eye but said it was around it and gave me shingles medicine.   I also had a rash all over my torso that went to the under side of my arms around the same time.  My eye got worse, scabs, sharp pains in the eyeball, draining eye, swollen. a week later so I went to the primary care again and he said it was an unknown virus on my eye and my torso and arms were an unknown viral rash.  He gave me predisone and prespription eye drops and I started to get relief and the rash went away.   this past week my eyebrow started to scab over and is spreading farther.  My eye puffy at times and my eyeball has some pain.   My nostril on the opposite side is having scab inside as well.  My back is also experiencing pain, not debilitating. I contacted my primary care doctor again today and the dr is to get in touch with me about it.
2. patient admitted 2/14/22 with atrial fibrillation on warfarin, CKD III who presented to ER with a mechanical fall, L femoral neck fracture, rapid atrial fibrillation, and acute respiratory failure with hypoxia due to COVID-19. patient died 2/18/22 at 01:39.
Initial report was received 12 October 2012 from a health care professional who provided identifying information for one patient out of a cluster of approximately 18 patients who tested PCR positive for influenza A/H3 since January. The other patients have been captured in case numbers 2012-05658, 2012-05659, 2012-05660, 2012-06067, 2012-06068, 2012-06069, 2012-06070, 2012-06071, 2012-06072, 2012-06073 and 2012-09566. A one-year-old male patient had received a 0.25 mL injection of FLUZONE, lot number UT4230AA on 18 November 2011 (route and site of administration not reported), and 102 days later, the patient tested PCR positive for influenza A/H3 at the state laboratory. The patient had previously received an injection of FLUZONE, lot number UT4119CA on 20 October 2011 (route and site of administration not reported), 131 days prior to the event. Approximate treatment date (treatments not specified) was reported as 28 February 2012. Outcome was recovered. Documents held by sender: None.
FAINTED; vision impairment (blackout); DIZZINESS; spinning; NAUSEA; VOMITED; over heating; chills; FATIGUE; CHILLS; over heating; A spontaneous report was received from a consumer concerning a female 55 years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced fainted, vision impairment (blackout), spinning, chills, fever, fatigue, nausea, dizziness, and vomited.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  The patient received their first of two planned doses of mRNA-1273 (Lot # 026L20A), intramuscularly (IM) (site not provided), on 05 Jan 2021. On 02-Feb-2021, the patient received their second of two planned doses of mRNA-1273 (lot #013M20A), IM (site not provided) for prophylaxis of COVID-19 infection.   On 05 Jan 2021, the patient received their first Moderna vaccine. On 06 Jan 2021, patient experienced chills and overheating. On 02 Feb 2021 the patient received second dose of Moderna vaccine and experienced chills and fatigue on same day. On 03 Feb 2021, the patient experienced overheating, nausea and vomited, dizziness, spinning, vision impairment (blackout), and fainted. Treatment was not administered.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.   Action taken with second dose of mRNA-1273 in response to the event was not provided The outcome of all events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested. Chills, Pyrexia, nausea, vomiting and fatigue are listed events.
Within minutes after vaccine, felt nauseated and shaky. Muscle pain in left arm was intense and lasted 3 days. Headaches, head pressure, neck pain and stiffness, extreme malaise, and difficulty concentrating began 2nd day after vaccine and are still current and worsening. I have had a recent physical with blood work that was perfect. I do have asthma which has been exacerbated since vaccine as well.
BG over 200 during fasting. Normally it is 80-100. High blood pressure and heart racing/pounding. Blurry vision due to the high BG. Problem is all these effects have lasted over two weeks despite my attempts to fix it by increasing diabetes medication and keep to an even stricter diet: 0 carbs < 500 calorie meals. 2 day intermittent fasting has no effect which usually gets my BG back in gear if I eat something bad. It seemed to get a little bit better just before my last shot, but now I'm back where I was. Feeling like I'm going to die. I'm on day 2, hopefully these symptoms will go away someday.
client complained of hot flash lasting a few seconds after receiving Janssen Covid Vaccine (lot 1808980, Exp 6/20/21). Client informed EMTs at 1335. Vitals: blood pressure 150/90, pulse 71, oxygen 95%. Per client felt hot flash for approximately 10-15 seconds. Client alert and oriented, normal skin color. History of COPD, allergy to penicillin. Client asked to stay for further observation. Vitals 1343: blood pressure 140/80, pulse 69, oxygen 94%. Client denied feeling any symptoms, hot flash resolved. Last set of vitals at 1400: blood pressure 120/80, pulse 70, oxygen 93%. Per client felt fine, no complaints. Client left facility with steady gait.
The day after receiving a flu vaccine she had discoloration and itching around the injection site. This was about 2 inches in diameter. Required MD visit 3 weeks after vaccine and dermatology visit on 4/5/17.
pt recv vax & 7 days post vax pt devel persistent itching of the lt arm;dermatologists plans to do patch testing for thimersol allergy;
pt experienced seizure and brought responsive to medical tent. Pt has hx of seizures and autism. Also had an itchy rash to chest. Epi 0.3 and 50mg Benadryl given.
Muscle aches and pain in left arm has continued for past month since receiving injection. I do have full function in arm.
Pt recvd 2 doses of Engerix-B & exp no reaction following 1st dose & stiff neck following 2nd dose;
Muscle ache; Fatigue; Headache; feels Achy; This is a spontaneous report from a contactable Physician. A female patient started to receive started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 17Dec2020 at single dose for covid-19 immunisation. This is unknown to her, but she would imagine the second dose is around 07Jan2021.  Medical history, concomitant medications or past drug history were not provided. The patient was experiencing that she was referring to is muscle aches, fatigue, and headache. She doesn't feel sickly but feels achy. It is unknown if the patient ever test positive for Covid, or had antibodies prior to the vaccine. Outcome of the events was unknown.  Information about Batch/Lot number has been requested.
4-11-2013 Not sure of onset date b/c didn't relate it at first. Difficulty breathing - especially lying down, extreme fatigue, muscle fasciculations, weakness in arms, no appetite, great weight loss, losing muscle, cough, runny nose, voice changing - hoarse, sleep a lot, bad breath with odd smell, hands shaking.
Cellulitis Lt upper arm (Td given because of cellulitis rt greate toe following pedicure).
Client woke up at 1am the night of the vaccination with Chills, Fever, chronic vomiting.  This continued for the next 36 hrs.  Took Phenergan on hand to stop vomiting at 5pm second day.  Continues  now with mild headache and chest congestion.
Within a few hours (about 5-6) after the vaccine was given a golfball sized knot appeared at the injection site.  It was red and hot and the swelling/knot is still very apparent 5 days later.  Very painful, unable to lift arm without causing severe pain.  Cannot sleep on left arm.
Patient developed hives to upper thighs, neck and shoulder and right arm,  Benadryl and Hydrocortisone Cream applied to area affected and resolved within 4-5 days
Patient is having pain on his whole left side, head to leg.  Right side also has pain but not as severe as the left.  Advised him to  seek medical help.
This spontaneous report was received from a medical assistant and refers to 19 patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates in 2017 (reported as beginning sometime in May 2017), the patients were vaccinated with improperly stored doses of ROTATEQ oral liquid, orally, lot # M034799 with expiration date on 01-FEB-2018 (dose and frequency were not reported). There were no adverse effects reported. Administered doses of the vaccine underwent temperature excursions of 31 degrees Fahrenheit or colder for 1027 hours and 32 degrees Fahrenheit to 35 degrees Fahrenheit for 587 hours. There were no previous temperature excursions. Digital data logger was not involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA005467: US-009507513-1709USA009874.
Soreness in arm. I couldn't even move my arm. Headaches Fatigue Thirst
This initial spontaneous report was received from a physician through a field representative, referring to a male patient of unknown age. Patient's concurrent conditions included bone marrow transplant. Other medical history was not reported. On an unknown date, the patient's wife (a 65 year old female) was vaccinated with ZOSTAVAX injection (dose, route, lot number and expiration date not provided). There was no concomitant medication described. Subsequently, she transmitted the herpes zoster virus to her husband which was at home as a bon marrow transplant patient. It was considered as a secondary transmission as the patient did not receive his own vaccination with ZOSTAVAX. Later, the patient developed disseminated herpes zoster which was treated at specified hospital. At the time of the report, the outcome of secondary transmission and herpes zoster disseminated was reported as recovered. Additional information has been requested.
positive test; positive test; This is a spontaneous report from a contactable consumer. A 56-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number and Expiry date: unknown, at the age of 56 years), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation in hospital. The medical history and concomitant medications were not reported. It was not known if patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient reported, positive test and loss of taste and smell on an unspecified date. She was previously vaccinated. The patient underwent lab tests and procedures which included sars-cov-2 test positive on an unspecified date. It was not known if the patient received any treatment for the events. Adverse event result in doctor or other healthcare professional office/clinic visit. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient presented with red rash spreading from injection site to inside of arm covering the top of his right bicep.  Rash spread over the course of 2 days from the injection site to before mentioned area of bicep.  Rash is tender to the touch and some swelling in the right arm is around the deltoid and bicep.  Patient was advised to use ibuprofen for swelling and benadryl and hydrocortisone for rash and tenderness.
Pt recvd a series of Engerix-B doses 2 yrs ago; Reporter indicated this past wk JUN91 pt tested HBSAG positive & is not protected; No tx given 17JUN91;
?COVID arm? a 6 inch warm to the touch rash that is swollen  and itchy/painful that began developing 2 days after receiving the vaccine
Due to a look-alike sound-alike error, Moderna Booster vaccine was administered instead of Moderna Bivalent vaccine. The Moderna Booster packaging was labeled "Booster" with no indication of whether it was bivalent or monovalent. Vials had blue caps similar to the bivalent vials. This packaging was sent after the state annouced that only bivalent could be used for booster doses. No adverse events or side effects reported. Mistake detected 12/14/2022.
Redness, swelling, and itching covering the entire upper arm area where the injection was given. Symptoms began 2 days after the second dose.
Swelling in the face; swelling in neck; swelling in eyes; rash on neck; Rash on face; Issues with Espphagus and lungs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Swelling in the face), SWELLING (swelling in neck), EYE SWELLING (swelling in eyes), RASH (rash on neck) and RASH (Rash on face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history has not been reported.     In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Swelling in the face), SWELLING (swelling in neck), EYE SWELLING (swelling in eyes), RASH (rash on neck), RASH (Rash on face) and VACCINATION COMPLICATION (Issues with Espphagus and lungs). At the time of the report, SWELLING FACE (Swelling in the face), SWELLING (swelling in neck), EYE SWELLING (swelling in eyes), RASH (rash on neck), RASH (Rash on face) and VACCINATION COMPLICATION (Issues with Espphagus and lungs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medication was not reported. The patient had been put on several rounds of steroids which helped temporarily but the rash and swelling retuned as soon as she tapered off.
At baseline he has some dysarthria/slurring of words and mild right sided hemiparesis.    Son (who is a Firefighter) was called by his sister who arrived at pt's house, where he found his father with delayed responsiveness, increased slurring/dysarthria, appearance of increased fatigue and confusion. He was then placed in ambulance - per son he cannot recall/remember if patient rhythm was Afibb when placed in ambulance.    Son reports the patient did test positive for COVID 10/1/21 - the reason he was tested was because his daughter and son in law were both tested and symptomatic, and given the patient's contact with them he too was tested. He has not exhibited any symptoms of shortness of breath or cough.    Per son, reported that for the 2 days prior to his admission here his blood sugars were significantly elevated running in the "400s" consistently.    Limited history obtained from patient, he responds with one word replies for majority of questioning, when asked if he has chest pain, shortness of breath, nausea, vomiting, abdominal pain he replies "no" to all.
24 hours after red ball appeared & swelling patient went to Dr & indicated shot caused her to get shingles & chicken pox.
Anxiety; Tinnitus; Palpitations; Depression; This spontaneous case was reported by a physician and describes the occurrence of ANXIETY (Anxiety), TINNITUS (Tinnitus), PALPITATIONS (Palpitations) and DEPRESSION (Depression) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine (Ocular migraine) and Anxiety.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced ANXIETY (Anxiety), TINNITUS (Tinnitus), PALPITATIONS (Palpitations) and DEPRESSION (Depression). The patient was treated with DIAZEPAM (VALIUM) ongoing since an unknown date for Anxiety, at an unspecified dose and frequency. At the time of the report, ANXIETY (Anxiety), TINNITUS (Tinnitus), PALPITATIONS (Palpitations) and DEPRESSION (Depression) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PALPITATIONS (Palpitations) and DEPRESSION (Depression) to be possibly related. No further causality assessments were provided for ANXIETY (Anxiety) and TINNITUS (Tinnitus).    Patient was using acupuncture treatment. No concomitant medication was reported. Physician seeing patient to evaluate for endocrine conditions.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Additional information received included no new information.
Information has been received from a physician concerning unspecified number of unspecified patients. On unspecified dates since 30-JAN-2015, the unspecified number of unspecified patients were administered an unspecified number of improperly stored doses of VAQTA (dose, strength and lot# were not reported, intramuscular). No adverse effects were reported. This case was one of the three cases received from the same reporter. (Other two cases were 1504USA002464 and 1503USA010732). Additional information has been requested.
Patient received booster despite being on active treatment for pneumonia. He received vaccine on evening of 12/8 and developed respiratory arrest on 12/9/21 with agonal breathing following by apnea. Time of death 12/9/21 at 15:12.
Pt recvd 1 dose of Engerix-B & tested pos for surface antigen to HBV 2 days p/receiving vax; 1JUN92 pt recvd  1 dose of Engerix-B & labs were drawn 2 days p/dose 1; surface antigen was pos & surface antibody was neg;
Fever 102, headache, pain in right shoulder/joint of arm injection given, can't lift arm high, pain radiated to fingers, body aches.  Has been taking Aleve every 10 hours, using heat and ice to site.  States if she does not take the Aleve every 10 hours, she can not lift her arm. DENIES: swelling at site, redness, nodule, or warmth @ site.  Discussed taking Ibuprofen if pt can tolerate med. Pt consulted PMD.
Soreness at site. Then on 12-20-11 at approx. 5:30PM noticed hives, welts around injection site, area was warm to touch & slightly itchy. Took 25mg BENADRYL at approx 6PM. Used Fluocinonide cream 0.05% twice a day, ALEVE for soreness. Followed up with PCP.
Pt was given vaccine in L thigh. At the 10-minute mark of the waiting period she vomited a small amount of undigested food. Roughly 2 minutes later pt began projectile vomiting undigested food in large quantities. This lasted 2-3 minutes. She tolerated this well, did not have any LOC, fussing or crying. VItal remained stable, cardiac and pulmonary exam WNL. 5 minutes later pt began vomiting again, this time asmall amount of mostly bile. She was given a few sips of water without issue.  Pt and mother were instructed to wait in the office for another 45 minutes for monitoring - no incidents occurred during this waiting period. They left the office. Instructed to seek emergency care for any lingering or severe symptoms (i.e; uncontrollable vomiting, lethargy, difficulty breathing). Increase fluid intake and feed smaller more frequent bland meals.
Patient has rheumatoid arthritis (immunocompromised) received 0.5 ml for her 2nd booster. The correct dose should be 0.25 ml.
Fever, chills, shivering, headache, stomach ache, and muscle pain (systemic and at the injection site)
9/5 Sore throat and body aches. 9/6 stomach ache/nausea. 9/9 covered in Hives -none allergy pill calamine lotion. 9/9 Urgent Care - methylprednisolone/BENADRYL. 9/9 Emergency Room - Cetirizine.
Bleeding for 32 days. I started bleeding 4 months after my 2nd vaccine and it didn't stop for 32 days. I just got my booster and now I'm on my second period in December.
waist they feel a pain that is horrible and comes and goes; itched a bit; got swollen; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN (waist they feel a pain that is horrible and comes and goes), VACCINATION SITE PRURITUS (itched a bit) and VACCINATION SITE SWELLING (got swollen) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01-A214) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced PAIN (waist they feel a pain that is horrible and comes and goes), VACCINATION SITE PRURITUS (itched a bit) and VACCINATION SITE SWELLING (got swollen). At the time of the report, PAIN (waist they feel a pain that is horrible and comes and goes), VACCINATION SITE PRURITUS (itched a bit) and VACCINATION SITE SWELLING (got swollen) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient states he does not take any concomitant medication. Treatment medication not reported